According to NRx Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.57. In 2022 the company made an earnings per share (EPS) of -$0.61 an increase over its 2021 EPS that were of -$8.03.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.57 | -6.56% |
2022 | -$0.61 | -92.41% |
2021 | -$8.03 |